Recent developments in cell-based immune therapy for neuroblastoma (Q80059433)

From Wikidata

Revision as of 03:38, 6 September 2024 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in es: BOT - Adding descriptions (1 languages): es)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on 02 March 2007

Language	Label	Description	Also known as
English	Recent developments in cell-based immune therapy for neuroblastoma	scientific article published on 02 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

Europe PubMed Central

Recent developments in cell-based immune therapy for neuroblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Michael R Verneris

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

John E Wagner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

2 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Journal of Neuroimmune Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

134-139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18040838%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral response to vaccination with interleukin-2-expressing allogeneic neuroblastoma cells after primary therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The function of gammadelta T cells in innate immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in the diagnosis and treatment of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of graft-versus-tumor effect in refractory metastatic neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological Evaluation of Pediatric Cancer Patients Receiving Recombinant Interleukin-2 in a Phase I Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of human neuroblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastoma update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NK cell receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: initial studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

gammadelta T cells: a new frontier for immunotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18040838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80059433&oldid=2244143518"